April 12th 2021
Infectious diseases are emerging at an alarmingly rapid pace, faster than any other time in human history.
July 23rd 2020
Microcephaly is not the only manifestation of developmental problems after antenatal exposure to the Zika virus. And even infants who appear normal at birth may display differences as they grow.
May 5th 2020
As children born in 2015-2016 with congenital Zika syndrome age, investigators are gradually able to assess neurodevelopmental outcomes.
January 30th 2020
According to new data, the prevalence of birth defects potentially related to Zika virus infection increased fourfold from January through March 2017 when compared with January to March 2016.
January 8th 2020
A study in JAMA Pediatrics suggests that infants exposed to Zika in utero who do not show signs of congenital Zika syndrome may still be at risk for abnormal neurodevelopmental outcomes.
ECDC Confirms Locally-Acquired Zika Cases in France
Zika virus was previously only found in regions of Asia, the Pacific Islands, South America, and Africa. ECDC has now confirmed 3 locally acquired cases in southern Europe.
HIV Drug Rilpivirine Stops Viral Replication of Zika Virus
By repurposing the HIV treatment rilpivirine, investigators have opened up possibilities for treating Zika virus and other flavivirus infections which overlap with HIV.
An Estimated 5700 Zika Cases Went Unreported in 2017 Cuban Outbreak
Although Cuba reported no cases of Zika virus in 2017 and 2018, investigators used travel data and genomic epidemiology to uncover a large, “hidden” Zika outbreak.
Adverse Outcomes From Zika May Hinge on Mother's Antibodies
Although antibodies normally shield us from infection, a new study suggests that certain maternal antibodies may actually make it easier for Zika virus to gain a foothold and cause birth defects.
Zika-Exposed Babies Can Experience Delayed Neurodevelopment in Second Year of Life
Of the 216 infants studied, 31.5% had delayed neurodevelopment and/or eye abnormalities and/or hearing deficits when evaluated as late as 32 months of age.
FDA Grants Marketing Authorization of Diagnostic Test for Zika Antibodies
ZIKV Detect 2.0 IgM Capture ELISA is the first diagnostic test authorized to detect Zika virus immunoglobulin antibodies in human blood and was previously available under Emergency Use Authorization.
Occupational Zika Risks for Lab and Biomedical Researchers
Deep-dives into Zika virus exposures shed light on how we can protect lab workers.
Tackling Zika Transmission at the Source With Genetically Engineered Resistant Mosquitoes
As several Zika virus vaccine candidates undergo clinical trials, a group of investigators is taking an alternate approach to quell transmission by genetically engineering mosquitoes to be resistant to the virus.
Zika Virus IgM Detected 12 to 19 Months Following Infection Onset, Study Finds
A new study reports that Zika antibodies persist for longer than initially believed, with antibodies detected in symptomatic patients 18 months after illness onset.
A History With Dengue Fever May Provide Some Protection From Symptomatic Zika
Investigators followed a pediatric cohort in Nicaragua over the course of 15 years and found that dengue fever immunity offers some protection against symptomatic Zika disease.
Severe Developmental Impairment Found in 15% of Toddlers Exposed to Zika in Utero
While most infants exposed to Zika in utero show no severe developmental defects, a new study offers an estimate of the impact of Zika-associated impairment within the first 2 years of life.
Prior Dengue Infection in Pregnant Women May Increase Risk of Severe Zika in Their Babies
Two new studies highlight how antibodies from prior infection with Zika or Dengue may increase the severity of illness in the other, impacting the infants of pregnant women who are infected.
Cytokines in Blood of Pregnant Women with Zika May Help Develop Prenatal Screening for Zika-Related Birth Defects
A new study examining cytokines in the blood of pregnant women infected with Zika may help investigators create a screening test for early detection of fetal abnormalities from the virus.
Zika: Where Are We Now?
The virus may be fading from mainstream headlines, but it is active and physicians must stay vigilant.
Health Officials in India Announce Third Zika Outbreak
The Government of India Ministry of Health and Family Welfare has announced 22 confirmed cases of Zika virus in Jaipur as of October 8, 2018.
NIH Launches Clinical Trial for Zika Virus Vaccine Candidate
The NIH has begun a phase 1 trial assessing the safety of rZIKV/D4Δ30-713, a Zika virus vaccine.
Top Infectious Disease News of the Week—August 12, 2018
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
CDC Issues New Guidance for Couples Trying to Conceive Following Exposure to Zika
The CDC now recommends that men who have been exposed to Zika use condoms or abstain from sex for 3 months to prevent sexual transmission of Zika.
One in 7 Babies Prenatally Exposed to Zika Virus Develop Birth Defects
The CDC reports that 1 in 7 infants exposed to Zika during pregnancy developed a birth defect or abnormality related to the virus.
Uganda Requests Removal from WHO Zika Travel Advisory List
The World Health Organization has listed Uganda on its Zika travel advisory list, but now the country’s health minister is requesting removal from the list, citing no cases or outbreaks.
New Study Examines Public Fears During Disease Outbreaks
Researchers studying how pregnant women in the United States responded to the Zika virus outbreak of 2015-2016 emphasize the need to manage stress and fear during disease outbreaks.
From Mobile Technology to Predictive Markers, Finding New Ways to Accurately Diagnose Zika
Current research trends indicate a need for updated guidelines and new technology to differentiate between Zika and other mosquito-borne infections.
New Technology Platform Delivers Single-Dose Vaccines Targeting Multiple Viruses
Single-dose vaccines delivered via a new technology platform may offer full protection against Zika, Lassa fever, and Ebola.
New Zika Research Highlights Potential Concerns as Mosquito Season Begins: Public Health Watch
Much about the virus and the proper public health response to outbreaks remains up for debate.
Scientists Identify Potential Target for Chikungunya Treatment
Researchers identify a molecule found on human cells and some animal cells that could be a potential target for drugs against chikungunya virus and related diseases.
FDA Approves New Claim for Zika Virus Test Allowing for Screening of Pooled Blood or Plasma Donations
The FDA has approved an additional claim for Roche’s cobas Zika virus test, allowing for the screening of several individual blood or plasma donations that have been pooled together.
Vector-Borne Disease Cases Have Tripled in the United States Since 2004
New CDC report warns of the growing burden of vector-borne diseases in the United States.
Mosquito-Borne Diseases Pose Growing Threat to United States
Experts need to be ready to respond to outbreaks of emerging mosquito-borne diseases in the United States.
Top 5 Infectious Disease News of the Week—April 22, 2018
In case you missed them, we've compiled the top five infectious disease articles from this past week.
New Findings on Zika in Semen May Change Recommendations on Preventing Sexual Transmission
A recent study sheds light on how long Zika virus can be transmitted through semen following infection, while another study assessed the side effects of Zika infection on infants with post-natal exposure.
2 Clarke Drive Cranbury, NJ 08512